The Safety and Tolerability of STSA-1301 Subcutaneous Injection in Healthy Subjects
Clinical trial NCT06148389 · COMPLETED
Trial details
- NCT number
- NCT06148389
- Sponsor
- Staidson (Beijing) Biopharmaceuticals Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-16
- Primary completion
- 2024-04-03
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.